Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Shifamed Announces $15.5M Series A Financing

Shifamed LLC
Posted on: 13 Jun 18
Shifamed Announces $15.5M Series A Financing Supira Medical, Newly Formed Portfolio Company, Focuses On Next Generation pVAD

PR Newswire

CAMPBELL, Calif., June 13, 2018

CAMPBELL, Calif., June 13, 2018 /PRNewswire/ -- Shifamed, LLC announced today the $15.5M financing of Supira Medical, the newest Shifamed portfolio company. The financing, led by The Capital Partnership (TCP) with participation from Cormorant Asset Management and Shifamed Angels, officially closed on April 25, 2018.

Supira Medical is focused on the development of a next generation percutaneous ventricular assist device (pVAD) for use in high-risk patients undergoing interventional procedures. The team is led by Jean Orth, appointed to CEO of Supira in December 2017, with the company located in Shifamed's state-of-the-art facility in Silicon Valley.

"I am delighted Jean will lead the Supira team and spearhead the company's early development efforts. The closing of this significant round of early-stage financing is a testimony to the large, unmet clinical need Supira's technology will address," commented Amr Salahieh, Founder of Shifamed and Chairman of Supira.  "Jean's 25+ years of cardiology-centric medical device experience, which includes her previous role as Executive VP of Business Development at Shifamed, makes her an ideal fit for Supira at this important time."

Since its inception in 2009, Shifamed has successfully incubated and sold three portfolio companies with an additional three companies funded and in development. Shifamed's legacy portfolio companies include Maya Medical (acquired by Covidien), Kalila Medical (acquired by Abbott/Terumo), and most recently Apama Medical (acquired by Boston Scientific).

Shifamed's current portfolio consists of Atia Vision developing a next generation of accommodating intraocular lens, NuVera Medical developing a novel imaging platform for use during complex cardiovascular interventions, and its most recent addition Supira Medical.

About Shifamed LLC
Founded by serial entrepreneur Amr Salahieh, Shifamed LLC is a privately held medical technology incubator focused on developing new medical products from concept to commercial release. To learn more about Shifamed, please visit www.shifamed.com.

MEDIA CONTACT:
Katie Arnold, SPRIG Consulting LLC
(408) 805-0520 | katie@sprigconsulting.com

 

View original content:http://www.prnewswire.com/news-releases/shifamed-announces-15-5m-series-a-financing-300664355.html

SOURCE Shifamed LLC

PR Newswire
www.prnewswire.com

Last updated on: 13/06/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.